Category Archives: Heart Diseases

The top five killers in India in 2050will be chronic obstructive pulmonary disease, ischemic heart disease, stroke, diarrhoeal disease and lower respiratory infections Cardiovascular disease, the top killer in 2022 globally, will continue to retain its position as the leading cause of death three decades later as well, a new study published in The Lancet warned. Ischemic heart disease also called coronary heart disease is caused by narrowed heart arteries that supply blood to the heart muscle, leading to a heart attack. In India, things look slightly different. Continue reading →

Tariq Shafi, MD, MHS Credit: LinkedIn Finerenone (Kerendia) may help reduce the decline in estimated glomerular filtration rates (eGFRs) in patients with chronic kidney disease (CKD) who have been hospitalized due to heart failure (HF). A new post hoc subgroup analysis from the pivotal phase 3 FIDELITY trial showed that CKD progression may be further limited in patients receiving the non-steroidal mineralocorticoid receptor agonist finerenone after they had been discharged from the hospital due to HFa specific patient population at a significantly greater risk of renal disease progression and death. The findings, presented at the National Kidney Foundation 2024 Spring Clinical Meeting (SCM) in Long Beach, CA, this week, would suggest that finerenone be considered as a post-discharge prescription in relevant patients with CKD Continue reading →

A T makes a difference in blood clotting. High cholesterol: two screens are better than one. Continue reading →

The medicine behind Ozempic and Wegovy, called semaglutide, could have significant benefits for heart health, reducing the risk of stroke or cardiac arrest even in those who don't lose weight. The data comes from the largest and longest clinical trial on semaglutide use amongst those without diabetes, called the Semaglutide and Cardiovascular Outcomes (SELECT) trial. This landmark study involved roughly 17,600 overweight or obese adults with pre-existing cardiovascular disease and was funded by the drug manufacturer, Novo Nordisk Continue reading →

A study in Denmark shows a rise in atrial fibrillation, with heart failure and stroke as major complications. Researchers emphasize the need for better prevention and treatment of heart failure alongside traditional focus on stroke prevention. Atrial fibrillation, often referred to as an irregular heartbeat, is a common cardiovascular condition. Continue reading →

Townsend, N. et al. Cardiovascular disease in Europe: epidemiological update 2016 Continue reading →

The chief executive of the British Society for Heart Failure, Lynn-Mackay-Thomas, spoke to New Statesman Spotlight about the charitys ongoing 25in25 initiative. Absolutely not. Heart failure is a formidable opponent in public health, with huge human and economic costs Continue reading →

This study consists of two distinct stages: the analysis of HTx program outputs and outcomes. The primary source of data was the Republican Center for Coordination of Transplantation and High-Tech Services, hereafter referred to as the Transplantation Coordination Center, under the Ministry of Health (MoH) of Kazakhstan. Functioning as the national agency providing technical support to all hospitals performing organ transplantations in Kazakhstan, this center is responsible for maintaining the medical information system, specifically the Registry of Donors and Recipients, which encompasses data on donors and recipients for various organ transplantations Continue reading →

For all the damage that microplastics are doing to the planet, it may be that only an impending threat to the human body will direct the kind of attention to the issue that it has long deserved. That moment, researchers say, is here. Several recent studies into microplastics, the voluminous and tiny (think 5mm or smaller) bits of material that can take hundreds of years to degrade, suggest that not only are they everywhere, but that theyre also making their way into our bloodstreamswith potentially hazardous results. Continue reading →

LITTLE ROCK, Ark., May 6, 2024 This year, more than 250 people dressed in red will attend the American Heart Association-Central Arkansas annual Go Red for Women Luncheon to honor survivors, celebrate advancements in heart health and chart a new course toward a world free of cardiovascular disease, which claims the lives of 1 in 3 women. Continue reading →